Astria Therapeutics Inc logo

Astria Therapeutics Inc

NAS:ATXS (USA)  
$ 12.61 -0.36 (-2.77%) 10:08 PM EST
At Loss
P/B:
4.09
Market Cap:
$ 710.11M
Enterprise V:
$ 669.60M
Volume:
654.07K
Avg Vol (2M):
769.22K
Volume:
654.07K
At Loss
Avg Vol (2M):
769.22K

Business Description

Astria Therapeutics Inc logo
Astria Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US14875P1075
Description
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.
Name Current Vs Industry Vs History
Cash-To-Debt 386.9
Equity-to-Asset 0.95
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 21.19
9-Day RSI 42.16
14-Day RSI 52.98
6-1 Month Momentum % 5.46
12-1 Month Momentum % -32.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 20.41
Quick Ratio 20.41
Cash Ratio 20.12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -136.8

Financials (Next Earnings Date:2024-03-22 Est.)

ATXS's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ATXS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Astria Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.2
Beta -0.2
Volatility % 111.84
14-Day RSI 52.98
14-Day ATR ($) 1.01016
20-Day SMA ($) 13.50875
12-1 Month Momentum % -32.21
52-Week Range ($) 4.26 - 15.6545
Shares Outstanding (Mil) 54.67

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Astria Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Astria Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Astria Therapeutics Inc Frequently Asked Questions

What is Astria Therapeutics Inc(ATXS)'s stock price today?
The current price of ATXS is $12.61. The 52 week high of ATXS is $15.65 and 52 week low is $4.26.
When is next earnings date of Astria Therapeutics Inc(ATXS)?
The next earnings date of Astria Therapeutics Inc(ATXS) is 2024-03-22 Est..
Does Astria Therapeutics Inc(ATXS) pay dividends? If so, how much?
Astria Therapeutics Inc(ATXS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1